Expression of the stress response oncoprotein LEDGF/p75 in human cancer: a study of 21 tumor types.
Expression of the stress response oncoprotein LEDGF/p75 in human cancer: a study of 21 tumor types.
复制标题
DOI:
10.1371/journal.pone.0030132
复制
发表时间:
2012
期刊:
影响因子:
3.7
通讯作者:
Casiano CA
中科院分区:
文献类型:
--
作者:
Basu A;Rojas H;Banerjee H;Cabrera IB;Perez KY;De León M;Casiano CA
Oxidative stress-modulated signaling pathways have been implicated in carcinogenesis and therapy resistance. The lens epithelium derived growth factor p75 (LEDGF/p75) is a transcription co-activator that promotes resistance to stress-induced cell death. This protein has been implicated in inflammatory and autoimmune conditions, HIV-AIDS, and cancer. Although LEDGF/p75 is emerging as a stress survival oncoprotein, there is scarce information on its expression in human tumors. The present study was performed to evaluate its expression in a comprehensive panel of human cancers. Transcript expression was examined in the Oncomine cancer gene microarray database and in a TissueScan Cancer Survey Panel quantitative polymerase chain reaction (Q-PCR) array. Protein expression was assessed by immunohistochemistry (IHC) in cancer tissue microarrays (TMAs) containing 1735 tissues representing single or replicate cores from 1220 individual cases (985 tumor and 235 normal tissues). A total of 21 major cancer types were analyzed. Analysis of LEDGF/p75 transcript expression in Oncomine datasets revealed significant upregulation (tumor vs. normal) in 15 out of 17 tumor types. The TissueScan Cancer Q-PCR array revealed significantly elevated LEDGF/p75 transcript expression in prostate, colon, thyroid, and breast cancers. IHC analysis of TMAs revealed significant increased levels of LEDGF/p75 protein in prostate, colon, thyroid, liver and uterine tumors, relative to corresponding normal tissues. Elevated transcript or protein expression of LEDGF/p75 was observed in several tumor types. These results further establish LEDGF/p75 as a cancer-related protein, and provide a rationale for ongoing studies aimed at understanding the clinical significance of its expression in specific human cancers.
登录
查看更多内容
影响因子:
3.8
作者:
McCready J;Sims JD;Chan D;Jay DG
通讯作者:
Jay DG
影响因子:
11.2
作者:
Daugaard, Mads;Kirkegaard-Sorensen, Thomas;Jaattela, Marja
通讯作者:
Jaattela, Marja
影响因子:
7
作者:
Chen, GA;Gharib, TG;Beer, DG
通讯作者:
Beer, DG
影响因子:
2.7
作者:
Morerio, C;Acquila, M;Panarello, C
通讯作者:
Panarello, C
影响因子:
37.3
作者:
Huang, Tien-sheng;Myklebust, Line M;Kjarland, Endre;Gjertsen, Bjorn Tore;Pendino, Frederic;Bruserud, Oystein;Doskeland, Stein Ove;Lillehaug, Johan R
通讯作者:
Lillehaug, Johan R